So Big Pharma’s argument about pricing goes like this: We spend a lot on R&D so we need to make a lot back when we find a winner. Now with Pharmasset we can look at the balance sheet immediately prior to Gilead’s purchase. At the time the sunk capital cost (accumulated deficit) was $324 million. […]
Tag Archives: hepatitis c success stories,
The thing with Hep C is that it’s not about anonymous statistics, it’s about real people. Here’s the story of one patient, and his wife’s journey through Interferon and failure and then to self initiated treatment and cure via the parallel import of generic DAA medications that was published in the Sydney Morning Herald and […]